Group by:
Date |
Item TypeArticle
Novel tetrazolo-pyridazine-based MACC1 transcriptional inhibitor reduces NFκb signaling pathway as key antimetastatic mechanism of action.
Schöpe, Paul Curtis, Dahlmann, Mathias, Kobelt, Dennis, Gohlke, Bjoern-O, Shoman, Abdelrhman M., Walther, Wolfgang, Preissner, Robert, Nazaré, Marc and Stein, Ulrike
Journal of Biotechnology and Biomedicine 8
(4): 356-369.
30 December 2025
This list was generated on Sun Mar 15 00:50:51 2026 UTC.
![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
![[up]](/style/images/multi_up.png)
Up a level
